alnylam
A Quality Control Analyst II at Alnylam supports sample management operations for internal and external GMP laboratories, ensuring high standards of quality and compliance for early-stage development through commercial programs. The role involves the qualification and inventory control of reference materials, data analysis, and documentation in compliance with GMP standards. Analysts collaborate cross-functionally with Quality Control, Quality Assurance, and CMC teams to ensure reference material availability and support inspection readiness activities.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
9% below the average for this role
Senior Manager, CMC Quality Assurance
altoneuroscience
Associate Director, Quality Control
Beam Therapeutics
Lab Compliance Manager
Vaxcyte
Senior Director, Quality Control
Dyne Therapeutics
GMP Chemist -Reference Standards
Eurofins
Director, Environmental Monitoring & Microbiology GMP Laboratories Lilly Medicine Foundry
Eli Lilly and Company